Thinkerbell Labs have developed the world’s first self-learning braille device for the visually impaired.
Cambridge Cancer Genomics ensures that each patient has the right treatment, at the right time, to beat their cancer.
Bios develop cutting edge treatments, such as a prosthetic interface device that allows amputees to control a connected body part, that combine advances in hardware, big data and AI.